Your browser doesn't support javascript.
loading
In Rheumatoid Arthritis, A Review of ncRNAs Related to NF-κB Signaling Pathways.
Wang, Chun-Xia; Cheng, Hsiang-Hung; Luo, Mei; Jiang, Jing-Rong.
Afiliação
  • Wang CX; Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, 610075, China.
  • Cheng HH; Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, 610075, China.
  • Luo M; Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, 610075, China.
  • Jiang JR; Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, 610075, China.
Article em En | MEDLINE | ID: mdl-38424418
ABSTRACT
Rheumatoid arthritis (RA) is an autoimmune disease with no known cure that results in joint deformities and dysfunction, significantly impacting the quality of life of patients. The abnormal NF-KB signaling pathway in RA has emerged as a crucial research area for the development of RA therapies, with non-coding RNAs (ncRNAs) serving as a potentially meaningful avenue to regulate it. Thus, understanding the role of ncRNAs in RA and the identification of new therapeutic targets have become pressing issues in the field. In this review, we aim to summarize recent studies on ncRNAs that regulate the NF-KB signaling pathway in RA, including miRNAs, lncRNAs, and circRNAs, as well as the mechanisms by which drugs modulate NF-K B activity. By highlighting these recent advances, we hope to promote further research into targeted RA therapy and provide novel directions and ideas for researchers in the field.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Curr Pharm Biotechnol Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Curr Pharm Biotechnol Ano de publicação: 2024 Tipo de documento: Article